Publications Office of the EU
ACORD CADRU MEDICAMENTE CADRIOVASCULARE - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

ACORD CADRU MEDICAMENTE CADRIOVASCULARE

Overview
  • Awarded
    05/03/2025
  • Today
    27/04/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
SPITALUL CLINIC C.F. CLUJ
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: RO113 Cluj
Business sector (Main CPV)
33622000 Medicinal products for the cardiovascular system
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
3,988,473.80 RON
Number of lots
155
Procedure details
Tender reference number
4288349_2023_PAAPD1428195
Description

Medicamente cardiovasculare. A se vedea Caietul de sarcini.Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 12-a zi inainte de termenul limita stabilit pentru depunerea ofertelor, Nr zile pana la care se pot solicita clarificari inainte de data de depunere a ofertelor este 20.

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
RO România
RO113 Cluj
CPV code

33600000 - Pharmaceutical products

33673000 - Medicinal products for obstructive airway diseases

33675000 - Antihistamines for systemic use

33696000 - Reagents and contrast media

33621400 - Blood substitutes and perfusion solutions

33621300 - Antianaemic preparations

33621100 - Antithrombotic agents

33621000 - Medicinal products for the blood and blood-forming organs

33642200 - Corticosteroids for systemic use

33642100 - Pituitary, hypothalamic hormones and analogues

33613000 - Laxatives

33611000 - Medicinal products for acid related disorders

33622800 - Agents acting on the renin-angiotensin system

33622700 - Calcium channel blockers

33622600 - Beta-blocking agents

33632200 - Muscle relaxants

33692210 - Parenteral feeding solutions

33632100 - Anti-inflammatory and anti-rheumatic products

33615000 - Medicinal products used in diabetes

33670000 - Medicinal products for the respiratory system

33691200 - Anthelmintics

33632000 - Medicinal products for the musculo-skeletal system

33651000 - General anti-infectives for systemic use and vaccines

33651200 - Antimycotics for systemic use

33651620 - Diphtheria-tetanus vaccines

33622400 - Vasoprotectives

33661700 - Other nervous system medicinal products

33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system

33622300 - Diuretics

33661600 - Psychoanaleptics

33661500 - Psycholeptics

33622100 - Cardiac therapy medicinal products

33622000 - Medicinal products for the cardiovascular system

33661300 - Antiepileptics

33661200 - Analgesics

33661100 - Anaesthetics

33612000 - Medicinal products for functional gastrointestinal disorders

33662100 - Ophthalmologicals

33610000 - Medicinal products for the alimentary tract and metabolism

33631000 - Medicinal products for dermatology

33696800 - X-ray contrast media

33690000 - Various medicinal products

33692500 - Injectable solutions

33692300 - Enteral feeds

33692400 - Perfusion solutions

Lots (155)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.